Vietnam sees famous medical and pharma M&A deals in 2023
The year 2023 has witnessed many large M&A deals in the medical and pharmaceutical industry, with two international hospitals falling into the hands of foreign owners and a wave of foreign investors’ acquisitions of Vietnamese drug companies.
Two major hospitals acquired by foreign investors
A series of recent large mergers and acquisitions (M&A) involving international corporations has shown the development potential of the Vietnamese medical market. According to statistics, medical tourism in Vietnam is worth about $2 billion with more than 300,000 international visitors coming for examinations and treatment each year.
The largest M&A deal in the medical and pharmaceutical industry in 2023 was the acquisition of Ho Chi Minh City-based FV Hospital by Thomson Medical Group (TMG) from Singapore. It was also the largest healthcare acquisition in Southeast Asia since 2020.
The deal value reached $381.4 million, including $359.6 million up front and $21.8 million to be delivered when FV Hospital achieves certain performance milestones.
The purchase will be funded via the group’s internal resources and external borrowing from financial institutions.
The deal highlights the growing significance of Vietnam’s burgeoning healthcare market, the Singaporean firm said in a release.
“FV Hospital provides a strategic foothold for us in Vietnam and a gateway to grow and focus on future investments in this fast-growing market,” said Kiat Lim, TMG’s executive vice chairman.
Under the terms of the sales and purchase agreement, TMG has agreed to acquire all of Far East Medical Vietnam Ltd. (FEMV). FEMV operates a range of healthcare facilities in Vietnam, including the 220-bed multidisciplinary tertiary FV Hospital and a network of primary and specialist clinics.
FEMV, also called FV Group, currently has over 1,600 staffers, including more than 200 Vietnamese and expatriate doctors. FV Hospital has since 2013 operated an outpatient clinic known as FV Saigon Clinic in the heart of District 1, Ho Chi Minh City’s traditional business district.
In October, the HCMC-headquartered American International Hospital (AIH) unveiled a comprehensive strategic partnership agreement with Raffles Medical Group (RMG) of Singaporean billionaire Loo Choon Yong.
The two sides did not disclose the specific value, but in July, Savills Vietnam valued AIH at $45.6 million.
Under the deal, from October, RMG would engage in the governance and operation of AIH and develop a number of specialized services such as oncology and general surgery.
Previously, RMG said it would buy the majority of shares of My My Trading - Services Company Limited, the investor of AIH.
The AIH acquisition will help RMG capture growth opportunities from the boom in demand for private healthcare services in Vietnam. At the same time, it supports RMG's ambition to become a high-quality medical and healthcare service provider chosen by people in the region.
AIH officially came into operation in 2018 with a capacity of 120 inpatient beds and a staff of about 500. This is a project of Tien Phuoc Group, a long-standing real estate developer in Ho Chi Minh City.
"Wave" of pharmaceutical M&As
In August, South Korean pharmaceutical group Dongwha Pharm spent KRW39 billion (about $30 million) to buy a 51% stake in Vietnam’s Trung Son Pharma. This is considered the biggest value deal in the pharmaceutical industry.
For a long time, Dongwha had intended to make deeper inroads into the Vietnamese market with many products distributed by the firm. Witnessing the growing demand for Korean vitamins, red ginseng and beauty care products in Vietnam, Dongwha plans to boost sales of these products.
Trung Son Pharma is a famous name in the Vietnamese pharmaceutical market, with a chain of 140 stores across throughout the southern region.
This brand was founded in 1997 by the couple of doctor Truong Thanh Son and pharmacist Truong Hoang Thanh Truc, offering diverse products from prescription drugs, over-the-counter (OTC) medicine, and supplementary foods, cosmetics and medical equipment, to healthcare and beauty products.
Since 2019, Trung Son Pharma has grown an average of 46% per year, reaching a revenue of VND13.5 trillion ($554.76 million) in 2022.
Another notable deal in the pharmaceutical industry in 2023 was Japan’s ASKA Pharmaceutical Group spending VND180 billion ($7.4 million) to increase its ownership in Ha Tay Pharmaceutical JSC (DHT). When the deal is completed, ASKA will hold 26.8 million DHT shares, or nearly 33% of charter capital.
DHT plans to spend VND78 billion ($3.21 million) building a high-tech pharmaceutical factory and the remaining VND102 billion restructuring bank loans to improve its financial self-sufficiency and reduce financial pressure.
In addition, the DHT board of directors decided to temporarily cap the foreign ownership ratio at 44.31%.
Established in 1920, ASKA specializes in providing products for internal medicine, obstetrics and gynecology and urology. In April 2020, the company established an international business department to promote growth and development through operations in foreign markets.
The Japanese pharmaceutical company said the purpose of this transaction is to establish a base in Southeast Asia as a launch pad for expanding operations in the international market.
In early 2021, ASKA completed a deal to buy 6.6 million DHT shares, becoming the largest shareholder in this pharmaceutical company with a 24.9% stake.
In April, Poland’s Adamed Pharma announced that it had bought a 100% stake in Dat Vi Phu Pharmaceuticals JSC (DaviPharm). This was considered the pharmaceutical industry's first major M&A deal in 2023.
The deal value was not disclosed, but the Polish group's presence at DaviPharm is expected to help the company become one of the largest drug manufacturers and a provider of high-quality drugs at affordable prices in Vietnam, as stated by Dr. Malgorzata Adamkiewicz, head of the company’s supervisory board.
Previously, Adamed Pharma owned 70% of DaviPharm shares.
Founded in 1986 in Poland, Adamed Pharma is a giant in the field of pharmaceuticals and biotechnology. By the end of 2022, the group owned two manufacturing plants in Poland and one in Vietnam, with over 200 patents in many countries around the world.
DaviPharm is a manufacturer of more than 300 medicinal products in Vietnam, Cambodia, Philippines and Myanmar. It owns a factory capable of producing up to 1.2 billion tablets per year in the southern province of Binh Duong.
Vietnam's healthcare market was worth $16.2 billion in 2020, accounting for 6.0% of GDP, said Vietnam Report, a leading local ranking and research company.
Total health spending increased from $16.1 billion in 2017 to over $20 billion in 2021. It is projected to reach $23.3 billion in 2025 and $33.8 billion in 2030. Pharmaceutical spending also rose to over $6.6 billion in 2021.
- Read More
Tecombank Securities becomes largest broker in Vietnam by capital base
Techcombank Securities JSC (TCBS) has become the largest securities company in Vietnam by charter capital after finishing a rights offering last week.
Banking & Finance - Tue, November 19, 2024 | 9:11 am GMT+7
Vietnam airport operator ACV looks to better exploit non-aviation service potential: exec
Vietnam's airports operator ACV expects to earn $145 million from non-aviation services this year, accounting for around 18.83% of its total revenue, which is modest compared to other countries, said deputy general director Nguyen Duc Hung.
Top News - Tue, November 19, 2024 | 7:45 am GMT+7
The Investor to host seminar on removing legal bottlenecks for infrastructure, property investment
A seminar themed “Removing legal bottlenecks for infrastructure and property investment” will be organized by The Investor in Hanoi on Tuesday.
Economy - Tue, November 19, 2024 | 7:00 am GMT+7
Indonesia promises Asia-Pacific investors more incentives
Indonesian President Prabowo Subianto recently told the press that he will create more incentives and expand special economic zones (SEZs) so as to lure investors from Asia-Pacific.
Southeast Asia - Mon, November 18, 2024 | 11:01 pm GMT+7
Indonesia, Brazil enhance aviation cooperation
Indonesia's state-owned aircraft manufacturer, Dirgantara Indonesia (DI), and Brazilian aerospace company Embraer have signed a memorandum of understanding (MoU) to expand collaboration in the commercial aviation sector.
Southeast Asia - Mon, November 18, 2024 | 11:00 pm GMT+7
Indonesia eyes to become member of BRICS
Indonesian President Prabowo Subianto has shown his country’s desire to become a member of the BRICS - the alliance of major emerging economies initiated by Brazil, Russia, India, China, and South Africa.
Southeast Asia - Mon, November 18, 2024 | 10:57 pm GMT+7
Former Party chief, chairman of Vinh Phuc province face disciplinary action
Vietnam’s Central Inspection Committee has proposed disciplining Pham Van Vong, former Party chief of Vinh Phuc, and Phung Quang Hung, former chairman of the northern province, for violations related to Phuc Son Group.
Politics - Mon, November 18, 2024 | 9:17 pm GMT+7
Shaping a waterway into a key shipping channel: Viconship gets dredging nod
A major dredging project will allow safer ship navigation and increased cargo transportation capacity on the Hai Phong shipping channel, thereby enhancing competitiveness of Vinconship’s port system, says the company.
Companies - Mon, November 18, 2024 | 7:08 pm GMT+7
Former assistant to State President appointed general director of state-owned financial firm HFIC
Truong Tuan Anh, an official at the State President Office and former assistant to a state president, has been appointed general director of Ho Chi Minh City Finance and Investment Stated-owned Company (HFIC).
Companies - Mon, November 18, 2024 | 5:35 pm GMT+7
MBBank’s takeover of weak OceanBank to have limited impact on its credit profile: Fitch
Military Commercial Joint Stock Bank's (MBBank) takeover of Ocean Commercial Bank Limited (OceanBank) will have limited financial impact on the former’s credit profile, Fitch Ratings said Monday.
Banking - Mon, November 18, 2024 | 5:06 pm GMT+7
Win-win philosophy indispensable for sustainable growth: Bamboo Capital founder
A win-win cooperation strategy is not just desirable, but a necessary condition for sustainable development, says Nguyen Ho Nam, founder of Vietnam’s private conglomerate Bamboo Capital Group.
Bamboo Capital - Mon, November 18, 2024 | 4:46 pm GMT+7
Vietnam central bank resumes selling gold after 1-month hiatus
The State Bank of Vietnam (SBV), the country's central bank, on Monday announced that it will reactivate the sale of SJC-branded gold bars to meet market demand.
Banking - Mon, November 18, 2024 | 4:02 pm GMT+7
Vietnam 2nd biggest market of Thai giant Central Retail in Jan-Sept
Thailand’s leading retailer Central Retail earned a revenue of THB37.99 billion ($1.09 billion) in Vietnam in the first nine months of this year, up 0.9% year-on-year.
Companies - Mon, November 18, 2024 | 4:00 pm GMT+7
Singapore firm to invest in $19.7 mln garment factory in central Vietnam
Singaporean-based HGQ ASIA Pte., Ltd will pour nearly VND500 billion ($19.7 million) into building a garment factory in the south-central province of Binh Dinh.
Industries - Mon, November 18, 2024 | 2:23 pm GMT+7
IP developer KBC to raise $236 mln to restructure debts, augment capital
Kinhbac City Development Holding Corporation (KBC), a leading industrial real estate developer in Vietnam, will offer 250 million shares to 11 investors for more than $6,000 trillion ($236.4 million) to restructure its debts.
Companies - Mon, November 18, 2024 | 2:17 pm GMT+7
Vietnam's chemical giant Vinachem targets $500 mln trade turnover with Brazil in 2030
Vietnam’s state-run chemical group Vinachem and Brazil’s major trading firm Oceanside One Trading LLC say they will strive to boost their bilateral trade to $500 million in 2030.
Companies - Mon, November 18, 2024 | 12:32 pm GMT+7